The c-fes protooncogene is expressed at high levels in the terminal stages of granulocytic differentiation, but so far no definite function has been attributed to the product of this oncogene. To tackle this problem, the c-Jbs protooncogene expression has been inhibited in HL60 cells, and fresh leukemic promyelocytes of acute promyelocytic leukemia have been induced to differentiate with retinoic acid (RA) and dimethylsulfoxide (DMSO). Inhibition was obtained by incubating the cells with a specific c-Jbs antisense oligodeoxynucleotide. It was observed that the cells, rather than differentiating, underwent premature cell death showing the morphological and molecular characteristics of apoptosis. This process was inhibited by granulocyte and granulocyte/macrophage colony-stimulating factor, but not by interleukin 3 (IL-3), IL-6, or stem cell factor. Our present results demonstrate that the loss of cell viability that occurs during the in vitro differentiation of myeloid cells, after the complete inhibition of the c-Jbs gene product and treatment with RA-DMSO, is due to activation of programmed cell death. It is concluded that a possible role of the c-Jbs gene product is to exert an antiapoptotic effect during granulocytic differentiation.
T he c-Jbs protooncogene is the cellular equivalent of the v-Jes, the transforming oncogene of the Snyder-Theilen feline sarcoma virus (1, 2) . This gene has been mapped on chromosome 15q25-26 (3) and the complete sequence of the genetic locus has been reported (4) (5) (6) . The gene codes for a tyrosine kinase protein, the p92 :-feS (7) , that forms, together with the c-abl product, the family of the cytoplasmic tyrosine kinases (8) . The 5' region of this gene is unique when compared with the other tyrosine kinases of the src and receptors gene family (9, 8) . In spite of its localization near the breakpoint of the t (15;17) , characteristic of the acute promyelocytic leukemia (APL), 1 the c-Jes oncogene is not involved in this specific translocation (10, 11) . Previous studies in our laboratories did not show any alteration of the c-Jbs gene locus in the HL60 myeloid cell line as well, which has 1 Abbreviations used in this paper: APL, acute promyelocytic leukemia; AS, antisense; DP, direct primer; RA, retinoic acid; ILP, reverse primer; S, sense; SCF, stem cell factor; Vit. D3, la, 25-dihydroxyvitamin D3.
been accurately screened before our expression studies. These studies have shown that the c-Jbs mRNA is detectable at a considerable level in myeloid proliferating cells, and that the level of expression increases during the terminal differentiation to granulocytes and, though at lower level, to monocytes (12) (13) (14) . Other studies have shown that the c-Jbs gene product, the p92 c-fes protein, is detectable only in myeloid cells (15) (16) (17) (18) . To tackle the problem of the specific function of this gene in myeloid differentiation, we have inhibited the expression of the c-Jes protooncogene in HL60 cells induced to differentiate with retinoic acid (R.A) and DMSO, using the methodology of antisense oligodeoxynucleotides (19, 20) . Our results showed that HL60 cells treated for 5 d with c-Jbs antisense (AS) oligomer and induced to differentiate with RA and DMSO undergo to progressive cell death (21) . Rather than reaching the morphology of terminally differentiated granulocytic cells, the AS-treated cells retain their immature phenotype and begin to die after 15 h of treatment with the granulocytic differentiation inducers. After 4 d of this treatment, >90% of HL60 cells are dead, showing pycnosis and karyorrhexis. These morphological aspects suggest that the observed events are the expression of an apoptotic process rather than the consequences of a toxic effect of the AS treatment (22, 23) . In fact, the same c-Jes AS oligomer does not have any toxic effect on the HL60 cells induced to differentiate to monocytes or macrophages by la, 25-dihydroxyvitamin D3 (Vit. D3) or tumor-promoting activity (TPA) (21) . A set of experiments was therefore planned to characterize this cell death. Besides the morphology of the calls, apoptosis is characterized by a typical pattern of cleavage of DNA into integer multiples of ",,200-bp fragments, a length roughly corresponding to the amount of DNA in one nucleosome unit (24) . Furthermore, apoptosis has been found to be inhibited by several survival factors (25) , which in the hemopoietic system are mairtly growth factors such as IL-3, GM-CSF, IL-6, and G-CSF (26) . The dependence of the apoptotic process on protein synthesis has been shown in HL60 cells, where cycloheximide induces large scale apoptosis (27) . Our results indicate that both in HL60 calls and in freshly collected leukemic promyelocytes the inhibition of c-J~s expression after induction to granulocytic differentiation leads to the activation of nuclear events underlying programmed cell death.
Materials and Methods
Cell Cultures. HL60 cells were cultured in 24-well tissue culture plates. Each well contained 7 x 10 s cells/m1 in RPMI 1640 supplemented with 10% heat-inactivated FCS and 2 mM t-glutamine. Highly homogeneous leukemic blast cells, obtained by bone marrow biopsy of a patient with APL, M3 phenotype carrying the t(15;17), were cultured in the same medium. Differentiation was induced by addition of I/zM RA plus 1% DMSO. In these culture conditions, terminal differentiation was obtained after 5 d (21) . Morphology was assayed by cytocentrifugation followed by May Grunwald Giemsa (MGG) staining. Cytochemical reactions for naphthol-AS-D-chloroacetate esterase, a-naphthyl acetate esterase, and myeloperoxidase were performed by standards methods (28, 29) . Purified peripheral blood granulocytes or mononuclear cells were used as positive controls for cytochemical assays.
Synthesis and Purification of Oligomers.
Nonmodified deoxyribonucleotides were synthesized on an automated solid-phase synthesizer (381A; Applied Biosystems Inc.) by standard b-cyanoethyl-phosphoramidite chemistry, extracted several times with ammonium-hydroxide and ethanol precipitated as described (30) . All oligomers were lyophilized and suspended directly in cell culture medium. The sequences of synthesized oligomers and their relationship to the organization of c-~s coding regions (4, 5) are shown in Table 1 . Homology between the oligomers and the human sequences present in the GenBank data bank was no greater than 70%. Furthermore, the 5' region of the c-~s protooncogene, where the AS oligonucleotide was selected, can be considered unique (1, 5) . In fact, comparison with sequences of the genes encoding several protein kinases, particularly the tyrosine kinases belonging to the src family, revealed a low degree of homology (8, 9) .
Determination of Oligodeoxynucleotides Stability. All the experiments were performed with a single lot of FCS that had been inactivated at 65~ for 20 min, and selected for minimal nuclease activity Low specific radioactivity 3zp end-labeled (31) oligomers were added to the medium at a final concentration of 10/~M and incubated for 24, 48, 72 , and 96 h at 37~ Integrity of the oligomers was evaluated by PAGE. We selected a serum in which the oligodeoxynucleotides were stable for >24 h.
Delivery System of the c-fes Oligomers into Proliferating HL60 Cells. HL60 and fresh leukemic blast cells express high levels of transferrin receptor. We used in our experiments a delivery system based on receptor-mediated endocytosis to introduce the c-~s oligomers complexed with transferrin-polylysine conjugate into HL60 cells as described (32) . With this delivery system the oligomer uptake e~ciency was, in our hands, •10 times higher as compared with noncomplexed oligomers. The uptake efficiency was evaluated as described (33) . The DNA/RNA duplex resistant to $1 nuclease digestion was detected 4 and 24 h after culture of HL60 cells in the presence of labeled c-~s AS oligomer-transferrinpolylysine complex as described (21) .
Oligomer Treatment of the Cells. c-Jes sense (S) or AS oligomers were added to the cultures every 24 h to maintain a final concentration of ,'~10-15/~M. Control cultures were left untreated. After 3 d of oligomer treatment the culture medium was replaced with fresh medium, containing 10/zM c-~s S or AS oligomer. After 120 h of oligomer treatment ILA-DMSO was added to the cultures at the indicated concentration. The experimental conditions and incubation period for these inducers are detailed elsewhere (34, 35) . Recombinant human growth factors were added to different cell cultures after the inactivation of the c-fis gene product at the following concentrations: ID3 (5 ng/ml; Genzyme Corp., Cambridge, MA), IL-6 (10 U/ml; Sigma Chemical Co., St. Louis, MO), stem cell factor (SCF) (10 ng/ml; Genzyme Corp.), GM-CSF (20 ng/ml; Genzyme Corp.), G-CSF (1,000 U/ml; British Biotechnology Ltd., Cowley, Oxford, UK). The cytokines were added simultaneously with the differentiation inducers and in the presence of 10/~M of c-~s S or AS oligomers.
Detection of c-fes mRNA in HL60 Cells Untreated and Treated with c-fes or AS Oligomer.
Total cellular RNA was extracted from 7 x 10 s HL60 cells exposed to c-fis oligomers for 120 h and from untreated cells, in the presence of 10/zg ofEscherichia coti tRNA, using a modification of the guanidinium isothiocyanate procedure (36) . RNA was then reverse transcribed using 400 U of murine Moloney leukemia virus reverse transcriptase (MuLV R'I~ BRL Life Technologies Inc., Gaithersburg, MD) and 0.5 #g of c-J~s reverse primer (RP) oligomer for 1 h at 37~ in lx RT-PCR buffer (10 mM Tris, pH 8.3, 50 mM KC1, 1 mM MgClz, 10 mM DTT, 200 ~M dATP, dCTP, dGTP, dTTP). The oligomers used in the RT-PCR reaction are reported in Table 1 . The resulting specific eDNA fragments were amplified with 3 U of Taq polymerase (Promega Biotec, Madison, WI) in the presence of 0.5/~g of c-fis direct primer (DP) oligomer in lx RT-PCR buffer. Thus, a 258-bp fragment corresponding to the c-~s coding region, nucleotides (nt) 163-574 of the genetic locus, was generated during 35 cycles of PCR (94~ for 40 s, annealing at 50~ for 2 min, and at 72~ for 4 min). 50/~1 of the 100/~1 PCR volume was separated on a 4% Nusieve (FMC-Bio Products, Rockland, ME) agarose gel and transferred by the electroblotting procedure (37) to a Gene Screen membrane (NEN-DuPont, Boston, MA). The synthetic oligomer probe was end-labeled with 3,-[3~p]ATP by polynucleotide kinase as described (31) . Blots were hybridized with a c-fes oligomer probe, using the experimental condition described by Albretsen et al. (38) . As a control for the amount of RNA used as substrate, oligomers specific for the B2-microglobulin eDNA (39) were used, in a parallel amplification reaction. CA) equipped with a single 488-nM argon laser. Briefly, 106 cells were incubated in cell culture medium with 10 #M bromodeoxyuridine (BrdU) (Sigma Chemical Co.) at 37~ for 30 min. A mouse mAb against BrdU (anti-BrdU; Becton Dickinson & Co.) was bound to BrdU incorporated into neosynthesized DNA. The complex was detected by a rabbit fluorescent anti-FC antibody (Dako Patts A/S, Glostmp, Denmark). DNA histograms were generated from 70% ethanol-fixed and RNase-treated (1 mg/ml) cells. Cells were stained with propidium iodide (PI) (50 #g/ml) and analyzed using the DNA cell cycle analysis program (C-12/86). Every 24 h, for 5 d, at least 104 cells were subjected to replicate analysis with <5% standard error. Viability, determined by the trypan blue exclusion test, in untreated and oligomer-treated cultures after 5 d of growth was 90-95 %. Experiments were repeated several times. DNA Extraction and Analysis of DNA Fragmentation. DNA extraction was performed using a modification of the technique described by Gross-Bellard et al. (42) . Briefly, the cells were pelleted and washed twice in PBS. The pellet was suspended in 0.4 #1 of SEDTA (0.1 M NaC1, 50 mM NazEDTA, pH 7.8) containing 33 gl of 10 mg/ml proteinase K and 40 #1 of 10% SDS. The lysate was incubated for at least 4 h at 37~ then extracted once with 1 vol of SEEYT_A saturated phenol and 1 vol of CIA (2% isoamyl alcohol in chloroform). The supernatant was precipitated overnight at -20~ with 40 #1 of 3 M Na acetate, pH 5, 15/~g of E. coli tRNA, and 2.5 vol of cold 100% ethanol The pellet was suspended in 0.4 ml of lx TE buffer (10 mM Tris, 1 mM NazEDTA, pH 8), then 1 #1 of 10 mg/ml DNase-free RNAse was added, and the suspension was incubated for 15 min at 37~ A second digestion with proteinase K was carried out for 1 h at 37~ with 100 gl of proteinase K in SEDTA (1 ml of 10 mg/ml proteinase K and 9 ml of SEDTA) after addition of 10 #1 of 10% SDS. The DNA suspension was then extracted once with 0.5 ml of 1:1 phenol/chloroform isoamyl alcohol (CIA), and the supernatant was precipitated as before. The pellet, after washing with 70% ethanol, was vacuum dried and suspended in 50/A of lx TE buffer. DNA samples were then separated on 1.2% agarose gd in TBE buffer (90 mM Tris borate, 90 mM boric add, 2 mM EDTA) containing I mg/ml ethidium bromide. Table 1 .
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Treatment of Proliferating HL60 Cells with a Specific c-fes AS
Oligomer and Differentiation Inducers. As shown in Fig. 1, after 96 h of treatment with the c-fis AS oligomer, the corresponding m R N A is not detectable by the RT-PCR technique. However cell growth does not appear to be modified, since the proportion of cells in G1, S, and G2 phases of the cell cycle is not altered by antisense treatment (Fig. 2) and the cell doubling time is 23 h, i.e., the same observed in untreated and c-fis S oligomer-treated HL60 cells (data not shown). The differentiation of HL60 cells is also not modified after the disappearance of c-.~s mP, NA when TPA and Vit. D3 are used as inducers, although the TPA-treated cells show a reduced adherence capability. On the contrary, a completely different result is obtained when the c-~s AS oligomer-treated 
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DNA CONTENT (P.I. FLUORESCENCE) AS oligomer treatment, there is a sharp increase in the proportion of cells in the G~ phase of the cell cycle ( Table 2) .
Effects of c-fes AS Oligomer and Differentiation Inducers on
Fresh Leukemic Promyelocytes of APL, On fresh leukemic promyelocytes of APL, the treatment with c-Jbs AS oligomer and differentiation inducers has an effect very similar to that observed in HL60 cells. As shown in Fig. 4 , ~90% of the cells die after 4 d, whereas 40-60% of the untreated or S-treated cells are still alive.
Morphological and Molecular Characteristics of the HL60 Cell Death after Treatment with c-fes AS Oligomer and Induction to
Granulocytic Differentiation. As shown in Fig. 5 , the cell death is characterized by premature pycnosis followed by karyorrhexis without lysis of the cell. DNA double-strand cleavage produces fragments of'~ 185-200 bp, synchronously with the compaction of chromatin observed morphologically. This DNA ladder pattern is evident in the DNA extracted after 24 and 48 h of treatment with RA-DMSO and c-]bs AS oligomer (Fig. 6) . On the contrary, high molecular weight DNA is found in HL60 cells treated with the differentiation inducers alone or in association with c-Jbs S oligomer.
Protective Effects of Hernopoietic Growth Factors on Cell Death
Induced by Inhibition of c-fes Gene Expression in RA-DMSOtreated HL60 Cells. As previously reported, IL-3, IL-6, SCF, GM-CSF, and G-CSF were tested to examine their capability to compete with the apoptotic process induced by the inhibition of c-Jbs gene expression during granulocytic differentiation. The cytofluorometric analysis, carried out by the method described above, shows that II.-3, IL-6, and SCF have no protective effect (Fig. 7) . A quite different result is observed when GM-CSF and G-CSF are added to the cell cultures (Fig. 8) . As summarized in Fig. 9 , ,,o70% of the cells are protected both by GM-CSF and G-CSF, and the protection lasts for >3 d, since at 120 h of culture, >40% of the cells are still alive. Each experiment was repeated three times, and the variability was never >10%. On the contrary, treatment with IL-3, IL-6, and SCF does not result in any protective effect. Table 3 shows that 1L-3, IL-6, and SCF are unable to avoid the increase of the 2c/4c ratio, although this increase is delayed. G-CSF and GM-CSF, on the contrary, leave this ratio unmodified and very similar to controls. These results confirm that an early consequence of the induction of apoptosis is the increase in the 2c/4c ratio.
Discussion
In this work we demonstrate that the loss of cell viability that occurs during the in vitro differentiation of myeloid cells, after the complete inhibition of the c-Jbs gene expression and treatment with RA-DMSO, is due to activation of pro- grammed cell death rather than to an accelerated cell differentiation. In fact, cytospins prepared at several different intervals from 24 to 96 h of c-Jbs AS oligomer and inducers treatment never show the presence of cells with differentiated granulocytic morphology. Cytochemical studies (data not shown) have not allowed us to obtain any evidence of progress toward granulocytic or monocytic differentiation. The morphological and molecular aspects of the effect of c-Jbs inhibition in HL60 differentiating cells suggest that the precocious cell death is the consequence of an apoptotic process. Strong support for this conclusion is brought by the observation that GM-CSF and G-CSF promote cell survival in differentiating HL60 cells by interfering with the inactivation of the c-Jbs proto-oncogene and thus suppressing apoptosis (43, 44) . The molecular mechanism involved in the apoptotic process induced by c-Jbs inhibition needs to be identified. The apoptotic cell death is induced very early during the granulocytic differentiation of myeloid cells treated with the AS c-Jbs oligomer, occurring largely 24-48 h after the differentiation induction. HL60 cells undergo spontaneous apoptosis after terminal differentiation at least 6 d after RA-DMSO treatment (45) . Normal neutrophils also undergo apoptosis during inflammation, and it seems possible to conclude that apoptosis represents the physiological way of death in these cells (46) . In our experimental conditions, an important question is represented by the functional state of the cells involved in the process. In fact the function of the c-Jbs product seems to occur mainly in granulocytic cells out of cycle, since the c-Jbs mRNA has been detected in increasing amounts in the terminal stages of granulocytic differentiation (12) (13) (14) . Furthermore, no effect on cell proliferation has been observed by the AS treatment of proliferating HL60 cells. The GM-CSF and G-CSF have no inhibitory effect on the growth of HL60 cells and no enhancing effect on differentiation (47) . Therefore the protective effect of G-CSF and GM-CSF is presumably related to events occurring in the short period when the cells, still in cycle, are drawn to terminal differentiation. The observation that at 24-48 h of AS c-Jbs treatment there is a sharp decrease in the proportion of 4c cells suggests that, as shown in other experimental systems (48) , precocious death of S, G2, and M cells is prevalent in these experimental conditions. This fact, and not a direct arrest in the G1 phase of the cell cycle, is, therefore, in our opinion the origin of the accumulation of 2c cells. survive for a long period of time in the peripheral blood with no significant proliferative activity and spontaneous differentiation (49) . Our data suggest the possibility that this prolonged survival is in some way related to the sustained expression of the c-Jes protooncogene in these cells (12) (13) (14) . The c-fis protooncogene might represent another example of an oncogene whose function is to prevent premature cell death. The function might therefore be similar, in granulocytic cells, to that of the bcl-2 oncogene in pre-B cells (50, 51) . Support for this hypothesis comes from the observation that the blast cells of promyelocytic leukemia are also sensitive to c-.~s AS oligomers when induced to differentiate with RA. The possibility to induce programmed cell death of promyelocytic cells during the early stages of induced granulocytic differentiation (52) should therefore be explored.
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